Agency: Hellenic Foundation for the Research & Innovation
Programme: Basic Research Financing Action, Sub-action II, Funding Projects in Leading-Edge Sectors
Title: SERENITY: Single biomarker characterization for the cure of Autoimmunity
Budget: 263.200€
Duration: 2023-2025
Role: Principal Investigator
Agency: Greek Secretariat for Research &
Technology
Programme: Flagship Actions
Title: Identification, confirmation and expoitation of the genetic basis of non-communicable multifactorial diseases for the development of new therapeutic approaches and reliable biomarkers
Budget: 4.915.000€ (SpilianakisLab: 150.000€)
Duration: 2023-2025
Role: Partner
Agency: University of Crete
Programme: Dissemination of Research Results, Category A'
Title: The interplay of SATB1 and BACH1 in gene regulation of T cells and the cause of autoimmunity
Budget: 2.500€
Duration: 2023
Role: Principal Investigator
Agency: European Union
Programme: H2020-MSCA-ETN-2018, GA-622934
Title: Joint Training and Research Program on Chromatin
Dynamics and the DNA Damage Response
Budget: 4.011.939€. (SpilianakisLab:
243.000€)
Duration: 2019-2022
Role: Partner